Leslie DeMars

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome

Jessica L. Dillon, Jorge Luis Valdés González, Leslie DeMars et al. · Human Pathology · 2017 · 85 citations

Medicine, Genetics, Oncology +14

Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay

Holly H. Gallion, Wayne A. Christopherson, Robert L. Coleman et al. · International Journal of Gynecological Cancer · 2006 · 64 citations

Medicine, Oncology, Pharmacology +11

Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer

Rodney P. Rocconi, Erin Stevens, Justin Bottsford-Miller et al. · Cancer Gene Therapy · 2021 · 23 citations

Medicine, Oncology, Pharmacotherapy +16